ReviewAmerican journal of translational research2025

Efficacy and safety of pembrolizumab in the treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis.

Kaiheng Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.